ProQR Therapeutics (PRQR) Revenue (2013 - 2025)

ProQR Therapeutics (PRQR) has 13 years of Revenue data on file, last reported at $5.5 million in Q4 2025.

• For the quarter ending Q4 2025, Revenue rose 18.57% year-over-year to $5.5 million; the trailing twelve-month figure through Dec 2025 stood at $17.9 million (down 12.45% YoY), and the FY2025 full-year result was $18.5 million, down 8.35% from the prior year.
• Revenue improved to $5.5 million in Q4 2025, from $3.4 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $14.6 million in Q1 2021 to a low of $273409.1 in Q4 2021.
• A 5-year average of $3.3 million and a median of $2.4 million in 2025 frame the typical range for Revenue.
• Across the five-year window, Revenue plunged 98.03% in 2021 and soared 587.63% in 2024, its largest moves.
• Tracing PRQR's Revenue over 5 years: stood at $273409.1 in 2021, then jumped by 168.67% to $734578.1 in 2022, then soared by 381.01% to $3.5 million in 2023, then jumped by 30.26% to $4.6 million in 2024, then increased by 18.57% to $5.5 million in 2025.
• Business Quant data shows PRQR's Revenue at $5.5 million in Q4 2025, $3.4 million in Q3 2025, and $4.3 million in Q2 2025.